Published in FDA Law Weekly, February 9th, 2006
The company sees this as a positive development since, as an FDA-approved OTC drug, PreHistin would not require a doctor's prescription, thus making consumer purchases easier, faster, and more convenient. Based on an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly